FHIR IG analytics
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| hl7.fhir.uv.xver-r4.r4b#0.1.0 | sct | SNOMED CT (all versions) |
Narrative
Note: links and images are rebased to the (stated) source
- Include these codes as defined in
http://snomed.info/sct version 📍http://snomed.info/sct/11000172109| Code | Display |
| 141191000172105 | Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device |
| 141201000172108 | Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device |
| 141231000172103 | temps pendant lequel la valeur glycémique est dans l'intervalle 'normal' de la catégorie diabétique |
| 141211000172106 | temps pendant lequel la valeur glycémique est dans l'intervalle 'bas' de la catégorie diabétique |
| 141221000172101 | tijd waarin de glycemische waarde binnen het interval 'zeer laag' van de categorie ligt |
| 141151000172102 | gemiddeld aantal scans per dag |
| 141171000172109 | aantal ernstige hypoglycemische voorvallen |
| 141141000172104 | Frequency of hyperglycaemic episodes |
| 365845005 | Hemoglobin A1C - diabetic control finding |
| 141161000172100 | Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device |
| 141121000172108 | coefficient de variation |
| 141131000172106 | nombre de jours de port du capteur |
| 141181000172107 | percentage opgenom |
| 141241000172105 | paramètre calculé sur la base du taux de glucose moyen |
Source1
{
"resourceType": "ValueSet",
"id": "be-vs-diabetes-observation-code",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"url": "https://www.ehealth.fgov.be/standards/fhir/glucose-monitoring/ValueSet/be-vs-diabetes-observation-code",
"version": "1.0.0",
"name": "BeVSDiabetesObservationCode",
"title": "BeVSDiabetesObservationCode",
"status": "draft",
"experimental": false,
"date": "2026-08-20T09:24:07+00:00",
"publisher": "eHealth Platform",
"contact": [
{
"name": "eHealth Platform",
"telecom": [
{
"system": "url",
"value": "https://www.ehealth.fgov.be"
},
{
"system": "email",
"value": "message-structure@www.ehealth.fgov.be"
}
]
},
{
"name": "Message-Structure",
"telecom": [
{
"system": "email",
"value": "message-structure@www.ehealth.fgov.be",
"use": "work"
}
]
}
],
"description": "Values to be used in the code of Diabetes observations",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "BE",
"display": "Belgium"
}
]
}
],
"compose": {
"include": [
{
"system": "http://snomed.info/sct",
"version": "http://snomed.info/sct/11000172109",
"concept": [
{
"code": "141191000172105"
},
{
"code": "141201000172108"
},
{
"code": "141231000172103"
},
{
"code": "141211000172106"
},
{
"code": "141221000172101"
},
{
"code": "141151000172102"
},
{
"code": "141171000172109"
},
{
"code": "141141000172104"
},
{
"code": "365845005"
},
{
"code": "141161000172100"
},
{
"code": "141121000172108"
},
{
"code": "141131000172106"
},
{
"code": "141181000172107"
},
{
"code": "141241000172105"
}
]
}
]
}
}
FHIR
FHIRsmith